Psychostimulant effects on motor and cognitive function in adults attention deficit hyperactivity disorder
Maurizio Cundari1,2,3, Lukas Kanold1, David Bergwall1
1Department of Experimental Medical Science, Faculty of Medicine, Lund University, Lund, Sweden.
Objectives:
This study aims to compare the performance on motor and cognitive functions of adult patients with attention deficit hyperactivity disorder (ADHD) with or without psychostimulant medication and controls. A secondary objective is to investigate differences on test performance across varying levels of disorder severity.
Methods:
We included patients with unmedicated ADHD (U-ADHD) (n = 52), patients with ADHD treated with psychostimulants (n = 40), and controls (n = 80). A multimodal set of motor and cognitive tests was administered to evaluate cerebellar and motor functions, attention and processing speed, executive functions, visuospatial perception, and visuospatial abilities.
Results:
Both patient groups performed significantly worse than controls across all functions. No significant performance differences were observed between the medicated and U-ADHD groups when disorder severity was not considered. However, some differences emerged when stratified by disorder severity. Patients with moderate to severe U-ADHD showed more impairments in sensorimotor functions compared to the medicated ADHD (M-ADHD), while those with mild U-ADHD displayed lower scores on visuospatial perception compared to M-ADHD. Regression analysis indicated that education, anxiety, and sleep disturbances minimally affect test performance.
Conclusions:
In summary, psychostimulant medication did not show consistent overall differences in motor and cognitive performance among adults with ADHD. Importantly, when stratifying by disorder severity, some group-level differences emerged, underscoring the need to account for disorder severity in future research and clinical assessment.
More Related Videos
05:48The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients
Published on: June 12, 2020
13:09Using Brain Activation nir-HEG/Q-EEG and Execution Measures CPTs in a ADHD Assessment Protocol
Published on: April 1, 2018
Related Concept Videos
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
